Landiolol Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB12212 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | lingual-facial-buccal dyskinesia | KG + DL |
| 2 | chronic tic disorder | KG + DL |
| 3 | psychogenic movement disorders | KG + DL |
| 4 | extrapyramidal and movement disease | KG + DL |
| 5 | benign shuddering attacks | KG + DL |
| 6 | primary orthostatic tremor | KG + DL |
| 7 | tremor-nystagmus-duodenal ulcer syndrome | KG + DL |
| 8 | benign paroxysmal tonic upgaze of childhood with ataxia | KG + DL |
| 9 | multiple system atrophy | KG + DL |
| 10 | variably protease-sensitive prionopathy | KG + DL |
| 11 | acute intermittent porphyria | KG + DL |
| 12 | open-angle glaucoma | KG + DL |
| 13 | primary hereditary glaucoma | KG + DL |
| 14 | phaeochromocytoma | KG + DL |
| 15 | hereditary late onset Parkinson disease | KG + DL |
| 16 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 17 | duodenum cancer | KG + DL |
| 18 | subarachnoid hemorrhage (disease) | KG + DL |
| 19 | hyperargininemia | KG + DL |
| 20 | adrenal gland pheochromocytoma | KG + DL |
| 21 | juvenile onset Parkinson disease 19A | KG + DL |
| 22 | carbamoyl phosphate synthetase I deficiency disease | KG + DL |
| 23 | heart cancer | KG + DL |
| 24 | small intestine cancer | KG + DL |
| 25 | sympathetic paraganglioma | KG + DL |
| 26 | parkinsonian-pyramidal syndrome | KG + DL |
| 27 | autonomic nervous system disease | KG + DL |
| 28 | headache disorder | KG + DL |
| 29 | atypical juvenile parkinsonism | KG + DL |
| 30 | trigeminal autonomic cephalalgia | KG + DL |
| 31 | extra-adrenal sympathetic paraganglioma | KG + DL |
| 32 | GTP cyclohydrolase I deficiency with hyperphenylalaninemia | KG + DL |
| 33 | adrenal gland cancer | KG + DL |
| 34 | miscellaneous movement disorder due to neurodegenerative disease | KG + DL |
| 35 | migraine disorder | KG + DL |
| 36 | malignant tumor of extrahepatic bile duct | KG + DL |
| 37 | duodenal neuroendocrine neoplasm | KG + DL |
| 38 | duodenal disease | KG + DL |
| 39 | X-linked parkinsonism-spasticity syndrome | KG + DL |
| 40 | duodenal villous adenoma | KG + DL |
| 41 | periampullary adenoma | KG + DL |
| 42 | ampulla of vater neoplasm | KG + DL |
| 43 | carcinoma of the ampulla of vater | KG + DL |
| 44 | duodenal adenocarcinoma | KG + DL |
| 45 | benign neoplasm of adrenal medulla | KG + DL |
| 46 | porphyria | KG + DL |
| 47 | epicardium cancer | KG + DL |
| 48 | benign prostatic hyperplasia (disease) | KG + DL |
| 49 | migraine with brainstem aura | KG + DL |
| 50 | malignant pericardial mesothelioma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.